CTLA4 and Miyoshi myopathy: Immune tolerance in MM is partly mediated by cytotoxic T-lymphocyte antigen 4 (CTLA-4) and PD-1, two immunomodulatory receptors expressed on T cells that trigger inhibitory pathways dampening T-cell activity.